The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118343345 11834334 5 F 201312 20160803 20151214 20160912 PER US-JNJFOC-20151201103 JANSSEN 67.18 YR E M Y 0.00000 20160912 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118343345 11834334 1 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET QD
118343345 11834334 2 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET QD
118343345 11834334 3 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET
118343345 11834334 4 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET QD
118343345 11834334 5 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET QD
118343345 11834334 6 PS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 202439 20 MG TABLET
118343345 11834334 7 SS ASA ASPIRIN 1 Oral 325 MG AND 81 MG DAILY Y 0 UNSPECIFIED
118343345 11834334 8 SS PLAVIX CLOPIDOGREL BISULFATE 1 Oral Y 0 75 MG UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118343345 11834334 1 Cerebrovascular accident prophylaxis
118343345 11834334 2 Cerebrovascular accident prophylaxis
118343345 11834334 3 Cerebrovascular accident prophylaxis
118343345 11834334 4 Atrial fibrillation
118343345 11834334 5 Atrial fibrillation
118343345 11834334 6 Atrial fibrillation
118343345 11834334 7 Product used for unknown indication
118343345 11834334 8 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
118343345 11834334 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118343345 11834334 Epistaxis
118343345 11834334 Upper gastrointestinal haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118343345 11834334 1 20130512 0
118343345 11834334 2 201311 201312 0
118343345 11834334 3 20131205 0
118343345 11834334 4 201311 201312 0
118343345 11834334 5 20130512 0
118343345 11834334 6 20131205 0